DEVELOPMENT of the first stem-cell treatment for Type 1 diabetes has been sped up after animal trials indicate the technique could cure the life-threatening hormonal disorder.
Johnson & Johnson with biotech company ViaCyte have already begun testing it in a small number of diabetic patients...